Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
First Claim
1. A method of inhibiting cephalic inflammation in a human patient, the method comprising intranasally administering to the patient a long-acting local anesthetic pharmaceutical composition in an amount effective to inhibit the cephalic inflammation.
0 Assignments
0 Petitions
Accused Products
Abstract
Methods, kits, apparatus, and compositions for inhibiting cephalic inflammation, including meningeal inflammation and cerebral inflammation for example, in a human patient are provided. The methods comprise intranasally administering to the patient a pharmaceutical composition comprising a local anesthetic, and preferably a long-acting local anesthetic ingredient. A composition useful for practicing the methods of the invention is described which comprises at least one local anesthetic in a pharmaceutically acceptable carrier, wherein the composition is formulated for intranasal delivery. A kit comprising the composition and an intranasal applicator is also included in the invention. Apparatus for delivering or applying the compositions of the invention or for performing the methods of the invention are also described.
227 Citations
32 Claims
- 1. A method of inhibiting cephalic inflammation in a human patient, the method comprising intranasally administering to the patient a long-acting local anesthetic pharmaceutical composition in an amount effective to inhibit the cephalic inflammation.
-
26. A method of inhibiting cephalic inflammation in a human patient, the method comprising anesthetizing a nerve structure associated with the disorder in the patient for a period effective to inhibit the inflammation.
-
32. A method of inhibiting cephalic inflammation in a human patient, the method comprising energizing a dorsonasally implanted electronic neural stimulator.
Specification